Loading...
XHKG0911
Market cap5mUSD
Dec 16, Last price  
0.27HKD
Name

Qianhai Health Holdings Ltd

Chart & Performance

D1W1MN
XHKG:0911 chart
P/E
—
P/S
0.05
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
58.50%
Rev. gr., 5y
65.23%
Revenues
961m
-51.00%
492,276,000762,970,0001,219,651,000835,531,000354,385,000197,062,00078,047,000587,808,000760,721,000283,398,0001,961,704,000961,291,000
Net income
-53m
L-75.11%
32,342,000128,613,000205,353,000-438,396,000-525,710,00035,861,0005,071,00026,715,000-6,408,0001,481,000-211,751,000-52,705,000
CFO
857k
P
4,786,00048,081,000-620,464,000-89,294,000144,512,000165,410,000-30,724,000-378,806,000-70,886,000-44,177,000-5,257,000857,000
Dividend
May 31, 20180.001 HKD/sh

Profile

Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products and electronic component products in Hong Kong. The company operates through Health-Care Products and Electronic Component Products segments. It offers Chinese herbal medicines, and skincare and other health-care products to wholesalers and retailers, as well as American ginseng, a perennial plant. The company is also involved in the sale of electronic components, including central processing unit, semi-conductor, etc. In addition, it engages in the trading of health-care products and electronic components; and money lending business. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited.
URL
http://www.qianhaihealth.com.hk/
IPO date
Jun 27, 2014
Employees
15
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
961,291
-51.00%
1,961,704
592.21%
283,398
-62.75%
Cost of revenue
1,013,645
1,904,577
288,034
Unusual Expense (Income)
NOPBT
(52,354)
57,127
(4,636)
NOPBT Margin
2.91%
Operating Taxes
(21,952)
(2,369)
Tax Rate
NOPAT
(52,354)
79,079
(2,267)
Net income
(52,705)
-75.11%
(211,751)
-14,397.84%
1,481
-123.11%
Dividends
Dividend yield
Proceeds from repurchase of equity
205
BB yield
-0.16%
Debt
Debt current
487
700
7,831
Long-term debt
487
1,674
666
Deferred revenue
Other long-term liabilities
Net debt
(18,551)
732
(11,973)
Cash flow
Cash from operating activities
857
(5,257)
(44,177)
CAPEX
(4)
(9)
Cash from investing activities
17,769
12,342
46,841
Cash from financing activities
(743)
(7,913)
(16,559)
FCF
(83,980)
378,092
(113,996)
Balance
Cash
19,525
1,642
2,470
Long term investments
18,000
Excess cash
6,300
Stockholders' equity
383,868
436,459
670,287
Invested Capital
384,601
437,892
672,064
ROIC
14.25%
ROCE
13.05%
EV
Common stock shares outstanding
1,694,450
169,450
169,300
Price
0.37
-57.95%
0.88
17.33%
0.75
-37.50%
Market cap
626,946
320.44%
149,116
17.44%
126,975
-37.49%
EV
608,396
149,848
115,002
EBITDA
(49,921)
59,561
(2,200)
EV/EBITDA
2.52
Interest
43
34
508
Interest/NOPBT
0.06%